BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 19821385)

  • 1. Alpha blockers prior to removal of a catheter for acute urinary retention in adult men.
    Zeif HJ; Subramonian K
    Cochrane Database Syst Rev; 2009 Oct; (4):CD006744. PubMed ID: 19821385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of alpha blockers prior to removal of urethral catheter for acute urinary retention in men.
    Fisher E; Subramonian K; Omar MI
    Cochrane Database Syst Rev; 2014 Jun; (6):CD006744. PubMed ID: 24913721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Types of indwelling urethral catheters for short-term catheterisation in hospitalised adults.
    Lam TB; Omar MI; Fisher E; Gillies K; MacLennan S
    Cochrane Database Syst Rev; 2014 Sep; (9):CD004013. PubMed ID: 25248140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised, placebo controlled, double blind study of alfuzosin SR in patients undergoing trial without catheter following acute urinary retention.
    Shah T; Palit V; Biyani S; Elmasry Y; Puri R; Flannigan GM
    Eur Urol; 2002 Oct; 42(4):329-32; discussion 332. PubMed ID: 12361896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The management of acute urinary retention in France: a cross-sectional survey in 2618 men with benign prostatic hyperplasia.
    Desgrandchamps F; De La Taille A; Doublet JD;
    BJU Int; 2006 Apr; 97(4):727-33. PubMed ID: 16536763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Types of urethral catheters for management of short-term voiding problems in hospitalised adults.
    Brosnahan J; Jull A; Tracy C
    Cochrane Database Syst Rev; 2004; (1):CD004013. PubMed ID: 14974052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study on the use of tamsulosin versus alfuzosin in spontaneous micturition recovery after transurethral catheter removal in patients with benign prostatic growth.
    Maldonado-Ávila M; Manzanilla-García HA; Sierra-Ramírez JA; Carrillo-Ruiz JD; González-Valle JC; Rosas-Nava E; Guzman-Esquivel J; Labra-Salgado IR
    Int Urol Nephrol; 2014 Apr; 46(4):687-90. PubMed ID: 24061764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Policies for the removal of short-term indwelling urethral catheters.
    Griffiths R; Fernandez R
    Cochrane Database Syst Rev; 2005 Jan; (1):CD004011. PubMed ID: 15674923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies for the removal of short-term indwelling urethral catheters in adults.
    Griffiths R; Fernandez R
    Cochrane Database Syst Rev; 2007 Apr; 2007(2):CD004011. PubMed ID: 17443536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Types of urethral catheters for management of short-term voiding problems in hospitalised adults.
    Schumm K; Lam TB
    Cochrane Database Syst Rev; 2008 Apr; (2):CD004013. PubMed ID: 18425896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does acute urinary retention respond to alpha-blockers alone?
    McNeill SA
    Eur Urol; 2001 Mar; 39 Suppl 6():7-12. PubMed ID: 11306895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alfuzosin 10 mg once daily increases the chances of successful trial without catheter after acute urinary retention secondary to benign prostate hyperplasia.
    Tiong HY; Tibung MJ; Macalalag M; Li MK; Consigliere D
    Urol Int; 2009; 83(1):44-8. PubMed ID: 19641358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Washout policies in long-term indwelling urinary catheterisation in adults.
    Hagen S; Sinclair L; Cross S
    Cochrane Database Syst Rev; 2010 Mar; (3):CD004012. PubMed ID: 20238325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of Urinary Retention in Patients with Benign Prostatic Obstruction: A Systematic Review and Meta-analysis.
    Karavitakis M; Kyriazis I; Omar MI; Gravas S; Cornu JN; Drake MJ; Gacci M; Gratzke C; Herrmann TRW; Madersbacher S; Rieken M; Speakman MJ; Tikkinen KAO; Yuan Y; Mamoulakis C
    Eur Urol; 2019 May; 75(5):788-798. PubMed ID: 30773327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate size influences the outcome after presenting with acute urinary retention.
    McNeill AS; Rizvi S; Byrne DJ
    BJU Int; 2004 Sep; 94(4):559-62. PubMed ID: 15329112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alfuzosin 10 mg once daily in the management of acute urinary retention: results of a double-blind placebo-controlled study.
    McNeill SA; Hargreave TB; Roehrborn CG;
    Urology; 2005 Jan; 65(1):83-9; discussion 89-90. PubMed ID: 15667868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Washout policies in long-term indwelling urinary catheterisation in adults.
    Shepherd AJ; Mackay WG; Hagen S
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD004012. PubMed ID: 28262925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical management of functional bladder outlet obstruction in adults with neurogenic bladder dysfunction.
    Utomo E; Groen J; Blok BF
    Cochrane Database Syst Rev; 2014 May; 2014(5):CD004927. PubMed ID: 24859260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tamsulosin for benign prostatic hyperplasia.
    Wilt TJ; Mac Donald R; Rutks I
    Cochrane Database Syst Rev; 2003; (1):CD002081. PubMed ID: 12535426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamsulosin in the management of patients in acute urinary retention from benign prostatic hyperplasia.
    Lucas MG; Stephenson TP; Nargund V
    BJU Int; 2005 Feb; 95(3):354-7. PubMed ID: 15679793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.